Physician profile
Rajeswara Rao Patcha
NPI 1104829407
$5,785.28
in general payments reported to CMS, 2019-2025
39 companies · $865 in 2025
The $865 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $574 · 2021: $728 · 2022: $1,107 · 2023: $541 · 2024: $659 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,046.26 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $718.14 | 2019-2025 | Watchman Flx, Rotapro, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $673.54 | 2019-2023 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $515.98 | 2019-2025 | |
| Medtronic Vascular, INC. | $418.58 | 2019-2020 | |
| Amgen INC. | $367.09 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $275.05 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| Pfizer INC. | $241.72 | 2019-2025 | |
| Amarin Pharma, INC. | $206.80 | 2019-2022 | |
| Astellas Pharma US INC | $174.39 | 2019-2022 | |
| Edwards Lifesciences Corporation | $168.17 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.85 | 2019-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.60 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $129.82 | 2019-2024 | |
| Shockwave Medical, INC | $125.40 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $116.62 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $115.49 | 2024-2025 | Acticor 7 Vr-T Dx, Biomonitor |
| E.R. Squibb & Sons, L.L.C. | $113.43 | 2020-2025 | Camzyos, Eliquis |
| Masimo Corporation | $107.20 | 2023 | Set and Rainbow Set |
| Abiomed | $97.61 | 2024 | Impella |
| Esperion Therapeutics, INC. | $84.38 | 2020-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $82.12 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $81.11 | 2019-2022 | |
| Philips North America LLC | $77.45 | 2020-2023 | |
| Kowa Pharmaceuticals America, INC. | $76.89 | 2019-2023 | Livalo |
| Kiniksa Pharmaceuticals International, Plc | $75.22 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $73.34 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bardy Diagnostics, INC. | $56.96 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $51.13 | 2019-2025 | Wainua |
| Irhythm Technologies, INC. | $44.41 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $41.68 | 2022-2023 | Ozempic, Rybelsus |
| Angiodynamics, INC. | $40.17 | 2024 | Auryon Laser System 100-120 Vac |
| Baxter Healthcare | $28.69 | 2024 | Hillrom - Connex Spot Monitor |
| Intra-Sana Laboratories | $25.46 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Braemar Manufacturing, LLC | $23.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.58 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.76 | 2025 | |
| Heartflow, INC. | $13.88 | 2025 | |
| Cardiovascular Systems INC. | $12.65 | 2023 | Diamondback Peripheral |
| Penumbra, INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeswara Patcha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.